Luteinizing Hormone-Releasing Hormone Agonist Triptorelin and Antagonist Cetrorelix Inhibit EGF-Induced c-fos Expression in Human Gynecological Cancers

Author： Grundker C.   Volker P.   Schulz K.-D.   Emons G.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.78, Iss.2, 2000-08, pp. : 194-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer

By Garcia Agustin  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 45-46

Informa Healthcare

Access to resources Recommend Favorite

Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer

By Verschraegen C.F.   Westphalen S.   Hu W.   Loyer E.   Kudelka A.   Volker P.   Kavanagh J.   Steger M.   Schulz K.-D.   Emons G.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 552-559

Elsevier

Access to resources Recommend Favorite

Pharmacological Studies with Cetrorelix (SB-75), a Potent Antagonist of Luteinising Hormone-releasing Hormone

By Reissmann T.   Klenner T.   Deger W.   Hilgard P.   McGregor G.P.   Voigt K.   Engel J.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1574-1579

Elsevier

Access to resources Recommend Favorite

Comparison of efficacy and safety of 1- and 3-month luteinizing hormone-releasing hormone agonist depots as initial therapies for prostate cancer

By Ishizuka Osamu  

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 524-530

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of Growth of Androgen-independent DU-145 Prostate Cancer In Vivo by Luteinising Hormone-releasing Hormone Antagonist Cetrorelix and Bombesin Antagonists

By Limonta P.   Pratesi G.   Moretti R.M.   Montagnani Marelli M.   Motta M.   Dondi D.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1134-1135

Elsevier

Access to resources Recommend Favorite